OSR Holdings Inc (OSRH) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.19 (-8.65%), Market cap $0.02B, 52-week low–high $0.40 ~ $1.67.
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Germany, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the comp
Financial statements, price targets, institutional (13F) holdings and related news for OSR Holdings Inc are updated in real time on BlackAll Trade.
OSR Holdings Inc trades at $0.19 (-8.65%). Real-time quotes and charts are available on BlackAll Trade.
OSR Holdings Inc has a market cap of about $0.02B.
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Germany, Switzerland, and South Korea. The company develops immunothe